The New Future of US Telehealth: Lasting Impacts of COVID-19

Ilya Trakhtenberg

future of US telehealth

COVID-19 expands use of telehealth

telehealth use cases

telehealth software ecosystem

eliminating telehealth barriers

COVID-19 and telehealth use cases

increased utilization of telehealth

hospital systems increase telehealth usage

virtual care and asynchronous visits biggest increases

structural and behavioral changes increase telehealth usage

patient and provider forced trial increase telehealth

waived regulatory and reimbursement restrictions with telehealth

forced trial to be lasting impact of COVID-19

telehealth expansion positive impacts and potential risks

telehealth evolution market

telehealth impact to payers and stakeholders

amazon and telehealth

For more information, please visit L.E.K.’s COVID-19 Insights Center or fill out this form to get in touch with us.

Related Insights

Life Sciences & Pharma

Executive Insights

A Lasting Legacy: Building a Successful Business From Established Brands

November 21, 2019

Legacy brands can form the foundation of a successful business, particularly for specialized players with the appropriate organizational structure and the…

Life Sciences & Pharma

COVID-19

COVID-19 Vaccine Research and Development Landscape - July 2020

August 5, 2020

COVID-19’s impact is first and foremost a global humanitarian crisis that has thrown us into uncharted territory, and we extend our sympathies to all who…

Life Sciences & Pharma

Executive Insights

Precision Medicine: Accelerating “Asia for Asia” Therapeutic Solutions Market Growth

August 21, 2019

Globally, there is a tremendous amount of precision medicine research underway to develop clinical therapeutics that are more targeted in their action and…

Strategy

COVID-19

Global Situation Report Insights: Edition 2

June 9, 2020

The L.E.K. Global Situation Report is a uniquely rich, current, and customisable collection of indicators that provide a powerful recovery planning aide.

Life Sciences & Pharma

Executive Insights

How Value-Based Contracts Bring Value to Biopharma

July 23, 2020

Biopharmaceutical executives have engaged in extensive debates about the need for and effectiveness of value-based contracts (VBCs) ever since the…

Life Sciences & Pharma

Executive Insights

AI in Biopharma: Realizing the Promise

October 31, 2019

Artificial intelligence (AI) should enable biopharma companies to tackle the entrenched inefficiencies of the costly and time-consuming drug development…